Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125528472 | 12552847 | 2 | F | 20160621 | 20160801 | 20160713 | 20160808 | EXP | JP-JNJFOC-20160702305 | JANSSEN | 70.00 | YR | E | F | Y | 54.00000 | KG | 20160808 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125528472 | 12552847 | 1 | PS | SIMPONI | GOLIMUMAB | 1 | Subcutaneous | Y | N | 125289 | 50 | MG | SOLUTION FOR INJECTION | ||||||
| 125528472 | 12552847 | 2 | SS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | Y | 0 | 10 | MG | CAPSULE | /wk | ||||||
| 125528472 | 12552847 | 3 | C | CARBOCISTEINE | CARBOCYSTEINE | 1 | Oral | 0 | 1500 | MG | TABLET | QD | |||||||
| 125528472 | 12552847 | 4 | C | TRAMCET | ACETAMINOPHENTRAMADOL | 1 | Oral | 4 DF (DAY FREQUENCY) | 0 | TABLET | |||||||||
| 125528472 | 12552847 | 5 | C | FOLIAMIN | FOLIC ACID | 1 | Oral | 0 | 5 | MG | TABLET | /wk | |||||||
| 125528472 | 12552847 | 6 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | 0 | 15 | MG | TABLET | QD | |||||||
| 125528472 | 12552847 | 7 | C | EDIROL | ELDECALCITOL | 1 | Oral | 0 | .75 | UG | CAPSULE | QD | |||||||
| 125528472 | 12552847 | 8 | C | TAKECAB | VONOPRAZAN FUMURATE | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 125528472 | 12552847 | 9 | C | VOGLIBOSE | VOGLIBOSE | 1 | Oral | 0 | .9 | MG | TABLET | QD | |||||||
| 125528472 | 12552847 | 10 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Oral | 0 | 1 | MG | TABLET | QD | |||||||
| 125528472 | 12552847 | 11 | C | AZILVA | AZILSARTAN KAMEDOXOMIL | 1 | Oral | 0 | 60 | MG | TABLET | QD | |||||||
| 125528472 | 12552847 | 12 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
| 125528472 | 12552847 | 13 | C | PRAVASTATIN NA | PRAVASTATIN SODIUM | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 125528472 | 12552847 | 14 | C | XYZAL | LEVOCETIRIZINE DIHYDROCHLORIDE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 125528472 | 12552847 | 15 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125528472 | 12552847 | 1 | Rheumatoid arthritis |
| 125528472 | 12552847 | 2 | Rheumatoid arthritis |
| 125528472 | 12552847 | 3 | Rhinitis |
| 125528472 | 12552847 | 4 | Pain |
| 125528472 | 12552847 | 5 | Prophylaxis |
| 125528472 | 12552847 | 6 | Prophylaxis |
| 125528472 | 12552847 | 7 | Osteoporosis |
| 125528472 | 12552847 | 8 | Gastrooesophageal reflux disease |
| 125528472 | 12552847 | 9 | Diabetes mellitus |
| 125528472 | 12552847 | 10 | Hypertension |
| 125528472 | 12552847 | 11 | Hypertension |
| 125528472 | 12552847 | 12 | Hypertension |
| 125528472 | 12552847 | 13 | Dyslipidaemia |
| 125528472 | 12552847 | 14 | Rhinitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125528472 | 12552847 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125528472 | 12552847 | Lung disorder | |
| 125528472 | 12552847 | Pneumocystis jirovecii pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125528472 | 12552847 | 1 | 20160208 | 20160530 | 0 | |
| 125528472 | 12552847 | 2 | 20160622 | 0 | ||
| 125528472 | 12552847 | 5 | 20160622 | 0 |